ONCY
Oncolytics Biotech Inc
0.631$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +39.3% | +15.0% | -41.8% | +0.5% | – | – | -5.3% | +338.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -19.8% | +23.3% | -20.6% | +49.1% | -64.2% | +15.2% | -26.7% | +163.0% | -45.1% | +53.7% | -6.4% | – | |
| – | -22.0% | -30.0% | +14.1% | -8.1% | -33.3% | +11.0% | -7.8% | +118.6% | +54.0% | -31.4% | +8.2% | – | |
| – | -19.9% | -1.4% | -9.2% | +25.0% | -52.2% | +6.2% | -16.9% | +138.5% | -2.9% | -3.8% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +514.3% | +85.4% | +19.2% | -87.4% | -5.1% | – | – | -391.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.